Immagene Biopharmaceuticals has raised $21 million in a Series B round led by Vertex Ventures China, while RongCloud Inc garnered “tens of millions of US dollars” in a Series D round jointly led by Shenzhen Capital Group and Electronic World Trade Platform (eWTP).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in